These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33197394)

  • 21. Disparities in spread and control of influenza in slums of Delhi: findings from an agent-based modelling study.
    Adiga A; Chu S; Eubank S; Kuhlman CJ; Lewis B; Marathe A; Marathe M; Nordberg EK; Swarup S; Vullikanti A; Wilson ML
    BMJ Open; 2018 Jan; 8(1):e017353. PubMed ID: 29358419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study.
    Álvarez-Antonio C; Meza-Sánchez G; Calampa C; Casanova W; Carey C; Alava F; Rodríguez-Ferrucci H; Quispe AM
    Lancet Glob Health; 2021 Jul; 9(7):e925-e931. PubMed ID: 34022148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance for face mask compliance, Chennai, Tamil Nadu, India, October-December, 2020.
    M J; Rubeshkumar P; Raju M; Sakthivel M; Murali S; Nagarajan R; Sendhilkumar M; Sambath I; Ilangovan K; Harikrishnan D; Venkatasamy V; Ganeshkumar P; Reddy M; Kaur P
    PLoS One; 2021; 16(9):e0257739. PubMed ID: 34559845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness of a community based prevention and treatment of acute malnutrition programme in Mumbai slums, India.
    Goudet S; Jayaraman A; Chanani S; Osrin D; Devleesschauwer B; Bogin B; Madise N; Griffiths P
    PLoS One; 2018; 13(11):e0205688. PubMed ID: 30412636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis.
    Bobrovitz N; Arora RK; Cao C; Boucher E; Liu M; Donnici C; Yanes-Lane M; Whelan M; Perlman-Arrow S; Chen J; Rahim H; Ilincic N; Segal M; Duarte N; Van Wyk J; Yan T; Atmaja A; Rocco S; Joseph A; Penny L; Clifton DA; Williamson T; Yansouni CP; Evans TG; Chevrier J; Papenburg J; Cheng MP
    PLoS One; 2021; 16(6):e0252617. PubMed ID: 34161316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia.
    Banjar A; Al-Tawfiq JA; Alruwaily A; Alserehi H; Al-Qunaibet A; Alaswad R; Almutlaq H; Almudaiheem A; Khojah AT; Alsaif F; Almolad SK; Alqahtani S; AlJurayyan A; Alotaibi A; Almalki S; Abuhaimed Y; Alkhashan A; Alfaifi A; Alabdulkareem K; Jokhdar H; Assiri A; Almudarra S
    Int J Infect Dis; 2021 Mar; 104():452-457. PubMed ID: 33465488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA.
    Thomas SN; Altawallbeh G; Zaun CP; Pape KA; Peters JM; Titcombe PJ; Dileepan T; Rapp MJ; Bold TD; Schacker TW; Arbefeville S; Ferrieri P; Thyagarajan B; Jenkins MK; Karger AB
    Clin Biochem; 2021 Apr; 90():15-22. PubMed ID: 33539808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
    Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
    Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Following the Largest Initial Epidemic Wave in the United States: Findings From New York City, 13 May to 21 July 2020.
    Pathela P; Crawley A; Weiss D; Maldin B; Cornell J; Purdin J; Schumacher PK; Marovich S; Li J; Daskalakis D;
    J Infect Dis; 2021 Jul; 224(2):196-206. PubMed ID: 33836067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses.
    Gozlan Y; Reingold S; Koren R; Halpern O; Regev-Yochay G; Cohen C; Biber A; Picard O; Mendelson E; Lustig Y; Mor O
    Epidemiol Infect; 2021 Jun; 149():e153. PubMed ID: 34372950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
    Popova AY; Smirnov VS; Andreeva EE; Babura EA; Balakhonov SV; Bashketova NS; Bugorkova SA; Bulanov MV; Valeullina NN; Vetrov VV; Goryaev DV; Detkovskaya TN; Ezhlova EB; Zaitseva NN; Istorik OA; Kovalchuk IV; Kozlovskikh DN; Kombarova SY; Kurganova OP; Lomovtsev AE; Lukicheva LA; Lyalina LV; Melnikova AA; Mikailova OM; Noskov AK; Noskova LN; Oglezneva EE; Osmolovskaya TP; Patyashina MA; Penkovskaya NA; Samoilova LV; Stepanova TF; Trotsenko OE; Totolian AA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence of SARS-CoV-2 in Pakistan: an update on epidemiological trends.
    Waqar M; Wahid B; Idrees M; Ali M; Rehman Z
    Z Naturforsch C J Biosci; 2021 Sep; 76(9-10):425-429. PubMed ID: 34161693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in seroprevalence between epicenter and non-epicenter areas of the COVID-19 outbreak in South Korea.
    Jeong HW; Chang HH; Kim EJ; Kim YK; Kim SM; Kim EH; Kim YI; Casel MAB; Kim SG; Rollon R; Jang SG; Yu KM; Kim HS; Park HS; Park SJ; Kim YD; Kim EG; Choi YK
    J Microbiol; 2021 May; 59(5):530-533. PubMed ID: 33907974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys.
    Kshatri JS; Bhattacharya D; Praharaj I; Mansingh A; Parai D; Kanungo S; Palo SK; Giri S; Pattnaik M; Barik SR; Dash GC; Choudhary HR; Turuk J; Mandal NN; Pati S
    Epidemiol Infect; 2021 Apr; 149():e139. PubMed ID: 33902776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal and neonatal health expenditure in Mumbai slums (India): a cross sectional study.
    Skordis-Worrall J; Pace N; Bapat U; Das S; More NS; Joshi W; Pulkki-Brannstrom AM; Osrin D
    BMC Public Health; 2011 Mar; 11():150. PubMed ID: 21385404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Living conditions, seroprevalence and symptoms of COVID-19 in slums in the Metropolitan Region of Vitória (Espírito Santo).
    Maciel ELN; Jabor PM; Macedo LR; Almada GL; Zanotti RL; Cerutti Junior C; Gomes CC; Alencar FEC; Reuter T; Andrade VLG; Cardoso OA; Medeiros Junior NF; Bastos WM; Bertolani MN; Silva LT; Zandonade E
    Rev Bras Epidemiol; 2021; 24():e210048. PubMed ID: 34730710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence to SARS-CoV-2 Among Healthcare Workers in an Exclusive Pediatric Hospital.
    Madhusudan M; Sankar J; Dhanalakshmi K; Putlibai S; Balasubramanian S
    Indian Pediatr; 2021 Mar; 58(3):279-280. PubMed ID: 33713065
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020.
    Kar SS; Sarkar S; Murali S; Dhodapkar R; Joseph NM; Aggarwal R
    Emerg Infect Dis; 2021 Feb; 27(2):666-669. PubMed ID: 33496645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Awareness and attitudes towards leprosy in urban slums of Kolkata, India.
    John AS; Rao PS
    Indian J Lepr; 2009; 81(3):135-40. PubMed ID: 20509342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.